BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19336448)

  • 1. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
    Song KY; Jung CK; Park WS; Park CH
    Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin expression and its clinical significance in pancreatic cancer.
    Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
    BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.
    Lu CD; Altieri DC; Tanigawa N
    Cancer Res; 1998 May; 58(9):1808-12. PubMed ID: 9581817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H; Lu C; Mabuchi H; Tanigawa N
    Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
    Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
    In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
    Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
    Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
    Potrc S; Gadiijev E; Hajdinjak T; Kavalar R
    Hepatogastroenterology; 2007; 54(73):308-14. PubMed ID: 17419281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of KAI1 expression in gastric cancer.
    Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
    Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
    Pizem J; Cör A; Gale N
    Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis.
    Sampaio-Góes FC; Oliveira DT; Dorta RG; Nonogaki S; Landman G; Nishimoto IN; Kowalski LP
    Head Neck; 2005 Nov; 27(11):982-9. PubMed ID: 16136583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.